|
head and neck cancer |
19 |
|
oral cancer |
17 |
|
artificial intelligence |
13 |
|
jaw reconstruction |
12 |
|
3d printing |
9 |
|
covid-19 |
9 |
|
machine learning |
9 |
|
simultaneous dental implant |
9 |
|
mandibular reconstruction |
8 |
|
patient-specific surgical plate |
8 |
|
virtual surgical planning |
8 |
|
computer-assisted surgery |
7 |
|
fibula free flap |
7 |
|
maxillary reconstruction |
7 |
|
survival |
7 |
|
cisplatin |
6 |
|
coronavirus |
6 |
|
essential services |
6 |
|
head and neck reconstruction |
6 |
|
meta-analysis |
6 |
|
oral and maxillofacial surgery |
6 |
|
orthognathic surgery |
6 |
|
reconstruction |
6 |
|
surgery |
6 |
|
xerostomia |
6 |
|
autophagy |
5 |
|
computer-aided design |
5 |
|
computer-assisted jaw reconstruction |
5 |
|
computer-assisted surgery (cas) |
5 |
|
cumulative sum analysis |
5 |
|
drug delivery |
5 |
|
free flap |
5 |
|
head and neck |
5 |
|
head and neck neoplasms |
5 |
|
internal fixators |
5 |
|
learning curve |
5 |
|
magnesium |
5 |
|
mechanistic target of rapamycin complex 1 |
5 |
|
melatonin |
5 |
|
nanoparticle |
5 |
|
nasopharyngeal carcinoma |
5 |
|
oncologic reconstruction |
5 |
|
patient-specific plates |
5 |
|
prospective clinical trial |
5 |
|
proto-oncogene proteins c-akt |
5 |
|
radiotherapy |
5 |
|
saliva electrolytes |
5 |
|
selective laser melting |
5 |
|
three-dimensional printing |
5 |
|
three-dimensional printing technology |
5 |
|
trpm cation channels |
5 |
|
virtual surgical planning (vsp) |
5 |
|
apoptosis |
4 |
|
cancer therapy |
4 |
|
class iii malocclusion |
4 |
|
computer-aided design and additive manufacture |
4 |
|
craniomaxillofacial reconstruction |
4 |
|
dental rehabilitation |
4 |
|
dentistry |
4 |
|
dentofacial deformity |
4 |
|
diagnosis and treatment |
4 |
|
free flap reconstruction |
4 |
|
functional reconstruction |
4 |
|
hpv |
4 |
|
long-term outcome |
4 |
|
mandibular prognathism |
4 |
|
microneedle |
4 |
|
online health |
4 |
|
oral health |
4 |
|
oral leukoplakia |
4 |
|
oral lichenoid lesions |
4 |
|
oral oncology |
4 |
|
oral potentially malignant disorders |
4 |
|
overall survival |
4 |
|
patient-specific implant |
4 |
|
patient-specific surgical guide |
4 |
|
pd-l1 |
4 |
|
photopolymer |
4 |
|
programmed death-ligand 1 |
4 |
|
radiographic imaging |
4 |
|
ramus osteotomy |
4 |
|
sagittal split |
4 |
|
social media |
4 |
|
software workflow |
4 |
|
squamous cell carcinoma |
4 |
|
stability |
4 |
|
surgeon-dominated |
4 |
|
til |
4 |
|
tumor-infiltrating lymphocytes |
4 |
|
accuracy |
3 |
|
adenoid cystic carcinoma |
3 |
|
arthrocentesis |
3 |
|
biomarkers |
3 |
|
bone plates |
3 |
|
cancer |
3 |
|
erastin |
3 |
|
facial pain |
3 |
|
ferroptosis |
3 |
|
hong kong |
3 |
|
immunotherapy |
3 |
|
le fort i osteotomy |
3 |
|
low-income countries |
3 |
|
lower-middle-income countries |
3 |
|
mandible reconstruction |
3 |
|
nerve-cancer crosstalk |
3 |
|
occlusal splints |
3 |
|
patient-specific implants |
3 |
|
patient-specific surgical plates |
3 |
|
prognosis |
3 |
|
prognostic signature |
3 |
|
reactive oxygen species (ros) |
3 |
|
reconstruction plate |
3 |
|
salivary gland |
3 |
|
secondary and tertiary prevention |
3 |
|
surgical techniques |
3 |
|
temporomandibular joint disorders |
3 |
|
tumor progression |
3 |
|
16s rrna sequencing |
2 |
|
adjuvant chemotherapy |
2 |
|
alkaline phosphatase |
2 |
|
ameloblastoma |
2 |
|
antimicrobial peptides |
2 |
|
antimicrobial resistance |
2 |
|
areca nut chewing |
2 |
|
bacteria |
2 |
|
bacterial dysbiosis |
2 |
|
bisphosphonate |
2 |
|
bmsc |
2 |
|
bone regeneration |
2 |
|
bone transplantation |
2 |
|
bone turnover |
2 |
|
btbd1 |
2 |
|
cancer surveillance |
2 |
|
clinical trial (topic) |
2 |
|
computer assisted surgery |
2 |
|
cone-beam computed tomography |
2 |
|
configuration |
2 |
|
conformation |
2 |
|
delay |
2 |
|
dental care |
2 |
|
dental implants |
2 |
|
diagnosis |
2 |
|
dna methylation |
2 |
|
drug holiday |
2 |
|
dysplasia |
2 |
|
endoscopy |
2 |
|
epigenomics |
2 |
|
epstein–barr virus |
2 |
|
exosomes |
2 |
|
fibroblast growth factor 19 (fgf19) |
2 |
|
fibula |
2 |
|
free flaps |
2 |
|
free tissue graft |
2 |
|
head and neck neoplasms/therapy |
2 |
|
hyperthyroidism |
2 |
|
induction chemotherapy |
2 |
|
insulin‐like growth factor‐1 receptor (igf‐1r) |
2 |
|
invasion |
2 |
|
lightweight |
2 |
|
local/therapy |
2 |
|
lymphoproliferative disorder |
2 |
|
lymphovascular invasion |
2 |
|
macrophage migration inhibitory factor (mif) |
2 |
|
mandibular prosthesis |
2 |
|
mechanical properties |
2 |
|
medication-related osteonecrosis of the jaw |
2 |
|
microbiome |
2 |
|
microsurgery |
2 |
|
microvascular reconstruction |
2 |
|
migration |
2 |
|
mir-200b-5p |
2 |
|
mirna |
2 |
|
mouth neoplasm |
2 |
|
mucocutaneous ulcer |
2 |
|
nanostructures |
2 |
|
neoplasm recurrence |
2 |
|
neoplasms metastasis |
2 |
|
nlr family pyrin domain containing 3 (nlrp3) |
2 |
|
obturators |
2 |
|
odontogenic keratocyst |
2 |
|
oral cancers |
2 |
|
oral squamous cell carcinoma |
2 |
|
oral squamous cell carcinomas |
2 |
|
oromandibular defect |
2 |
|
orthodontics |
2 |
|
osteoclast |
2 |
|
osteoporosis |
2 |
|
phosphotidylinositol‐3‐kinase (pi3k)/akt/mammalian target of rapamycin (mtor) |
2 |
|
pi3k/akt |
2 |
|
postoperative radiotherapy |
2 |
|
primary intraosseous carcinoma |
2 |
|
prognostic biomarker |
2 |
|
radicular cyst |
2 |
|
reconstructive surgery |
2 |
|
recurrence |
2 |
|
risk factor |
2 |
|
salivary adenoid cystic carcinoma (sacc) |
2 |
|
salivary gland cancer |
2 |
|
sars-cov-2 |
2 |
|
scaffold |
2 |
|
screening |
2 |
|
self-assembly |
2 |
|
short root anomaly |
2 |
|
sialoendoscopy |
2 |
|
submandibular gland |
2 |
|
systematic review |
2 |
|
timing |
2 |
|
tissue engineering |
2 |
|
tongue cancer |
2 |
|
tumor associated macrophages (tams) |
2 |
|
whole-exome sequencing |
2 |
|
adenocarcinoma |
1 |
|
amelioration |
1 |
|
angiogenesis |
1 |
|
animal experiment |
1 |
|
animal model |
1 |
|
animal tissue |
1 |
|
association analysis |
1 |
|
atg5 |
1 |
|
autogenous bone graft |
1 |
|
beclin 1 |
1 |
|
beclin-1 |
1 |
|
bone morphogenetic protein-2 |
1 |
|
bone target |
1 |
|
brca1 |
1 |
|
bregs |
1 |
|
buccal carcinoma |
1 |
|
buccal defect |
1 |
|
calculi |
1 |
|
cancer inhibition |
1 |
|
cancer recurrence |
1 |
|
cancer-associated fibroblasts |
1 |
|
carbon emissions |
1 |
|
case-control study |
1 |
|
cd40l |
1 |
|
cetuximab |
1 |
|
chemotherapy |
1 |
|
china |
1 |
|
cisplatin sensitivity |
1 |
|
city-level |
1 |
|
clinicopathologic features |
1 |
|
computed tomography |
1 |
|
contralateral nasolabial island flap |
1 |
|
covid‐19 |
1 |
|
data quality |
1 |
|
data-centric ai |
1 |
|
death-associated protein kinase-1 |
1 |
|
dental health |
1 |
|
double staining |
1 |
|
driving forces |
1 |
|
ductal access |
1 |
|
electrolyte |
1 |
|
enthesis |
1 |
|
femoral anterolateral myocutaneous |
1 |
|
foxp3 |
1 |
|
function |
1 |
|
glossectomy |
1 |
|
hydrogel |
1 |
|
il-10 |
1 |
|
imaging |
1 |
|
immunosuppression |
1 |
|
indian scenario |
1 |
|
inflammatory microenvironment |
1 |
|
inflammatory response |
1 |
|
interstitial fibrosis |
1 |
|
jaw neoplasms |
1 |
|
lidocaine |
1 |
|
magnetic resonance |
1 |
|
mandible defect |
1 |
|
mandibular defect |
1 |
|
masseter |
1 |
|
maxillofacial conditions |
1 |
|
mdsc |
1 |
|
medial upper arm free flap |
1 |
|
metastasis |
1 |
|
mff |
1 |
|
mir-593-5p |
1 |
|
mitochondrial dna copy number |
1 |
|
mitochondrial fission |
1 |
|
myocutaneous flap |
1 |
|
neoadjuvant chemotherapy |
1 |
|
neoplasm |
1 |
|
neoplasm metastasis |
1 |
|
obstructive submaxillaritis |
1 |
|
oral and maxillofacial reconstruction |
1 |
|
oral cavity reconstruction |
1 |
|
oral diseases |
1 |
|
osteogenesis |
1 |
|
osteosarcoma |
1 |
|
oxidative stress |
1 |
|
pandemic |
1 |
|
papillomaviridae |
1 |
|
parotid gland diseases |
1 |
|
passenger transport |
1 |
|
pectoralis major |
1 |
|
pedicled flap |
1 |
|
peritoneum |
1 |
|
phleboliths |
1 |
|
plastic surgery |
1 |
|
pten |
1 |
|
quality of life |
1 |
|
radioprotection |
1 |
|
raman spectroscopy |
1 |
|
receptor |
1 |
|
reconstructive surgical procedure |
1 |
|
rectus abdominis |
1 |
|
regeneration |
1 |
|
reinnervation |
1 |
|
review |
1 |
|
risk factors |
1 |
|
saliva |
1 |
|
saliva flow rate |
1 |
|
salivary biomarkers |
1 |
|
salivary calculi |
1 |
|
salivary ducts |
1 |
|
salivary gland scintigraphy |
1 |
|
salivary glands |
1 |
|
scintigraphy |
1 |
|
secretion |
1 |
|
sialadenitis |
1 |
|
sialolithiasis |
1 |
|
sialoscintigraphy |
1 |
|
squamous cell carcinoma of head and neck |
1 |
|
stensen's duct |
1 |
|
strategies for management |
1 |
|
stroma-infiltrating b cells |
1 |
|
submandibular gland diseases |
1 |
|
subtotal or total glossectomy defects |
1 |
|
swallowing |
1 |
|
t cell |
1 |
|
tongue |
1 |
|
tongue functional reconstruction |
1 |
|
tongue neoplasms |
1 |
|
tongue squamous cell carcinoma |
1 |
|
tongue squamous cells carcinoma (tscc) cells |
1 |
|
transplantation |
1 |
|
tree-based method |
1 |
|
tregs |
1 |
|
tumor |
1 |
|
tumor immunity |
1 |
|
tumor microenvironment |
1 |
|
ultraviolet radiation resistance-associated gene |
1 |
|
vascular malformation |
1 |
|
wharton's duct |
1 |
